Location: Home
  • search
  • go
  • Relate News
  • 12/21/2021NMPA Issues Announcement for Applicability of ICH Guidelines Q3C (R8)
  • 12/21/2021CStone announced New Drug Approval of Cejemly® (Sugemalimab) in China
  • 12/21/2021CFDI Issues Five New Registration Verification and Inspection Related ...
  • 12/21/2021Ping An Good Doctor and Chugai Pharma China Enter Strategic Partnershi...
  • 12/21/2021Toray and 3SBio File Chinese NDA for Orally Disintegrating Antiprurit...
  • 12/21/2021Pfizer Wins Chinese BLA Approval of Inotuzumab Ozogamicin for BCP-ALL
  • 12/21/2021As U.S. Takes Aim at China Drug Makers, Innovators Appear at Biggest R...
  • 12/21/2021Alibaba and JD.Com's Healthcare Units Prepare for Next Battle in Criti...
  • 12/20/2021China's First Drug Patent Linkage Case Highlights Loophole, Lawyer War...
  • 12/20/2021NHSA Issues the List of DRG/DIP Reform Demo Trial Sites
  • 12/20/2021NHC Issues the Guidelines for Building and Management of Pharmacy Intr...
  • 12/20/2021CDE Publicizes the List of Reference Formulations for GQCE Studies (53...
  • 12/20/2021CDE Issues the Technical Guidance on Clinical Pharmacology Research of...
  • 12/20/2021CDE Issues the Rules for Principles and Procedures of Drug Registratio...
  • 12/20/2021Novartis and BeiGene Expands Collaboration to BeiGene's TIGIT Inhibito...
  • 12/20/2021AI-Powered Drug Discovery Firm 20n Bio Raises $3.3M in Seed Funding
  • 12/20/2021MOF: China To Lower Import Tariffs on 954 Products in 2022
  • 12/20/2021Novartis Granted Chinese Approval of Its Anti-CD20 Antibody Ofatumumab...
  • 12/20/2021Xpovio Combo Conditionally Approved in China for Repeatedly Treated rr...
  • 12/20/2021Cytokinetics and Ji Xing Expand Collaboration for Omecamtiv Mecarbil i...
  • 12/17/2021CBMG Cleared of U.S. IND of Bi-Specific CAR-T Cell Therapy C-CAR039...
  • 12/17/2021BioMarin and Skyline Therapeutics in Deal to Co-develop Novel Gene The...
  • 12/17/2021IQVIA: Chinese Retail Pharmacy Sales Up Only 0.3% in Q3/2021
  • 12/17/2021Review of Retail Pharmacy Sales of VBP Prevailing and Failure Drug Pro...
  • 12/17/2021The IPO Plans of 16 Chinese Medpharm Startups Failed to Win SSE STAR A...
  • 12/17/2021Data Snapshot – The Landscape of Innovative Biologics in China
  • 12/17/2021Recent Executive Moves
  • 12/16/2021US Sanctions Chinese Painkiller Makers Amid Addiction Epidemic, As Sen...
  • 12/16/2021Zai Lab's NUZYRA Approved in China as a Class 1 New Drug for CABP and ...
  • 12/16/2021US Sanctions Chinese Tech Firms/Institutes for Weaponizing Biotech, Sp...
  • Page:100/719 Total number of articles:21546: [First][<<] [98] [99] [100] [101] [102] [>>] [End]
  • Site map | Contact Us | Links
  • © Wicon International Group